CRVS

Conviction 57HealthcareScan · Mon, Aug 10, 2026

CRVS$13.72-1.44%

ResistanceSupportVol 14Insider buy

Vol MA14 938.9K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Corvus Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.corvuspharma.com ↗

Price13.72

Change-1.44%

Gap-0.50%

Rel volume2.86×

Avg volume940.71K

Avg $ vol13.05M

SMA 2013.84

SMA 5013.39

SMA 20013.16

Price vs 50+2.46%

Price vs 200+4.29%

MA stackbullish

50/200 cross—

Supertrenddown · 15.25

RSI (14)49

MACD hist-0.00

MACD cross—

Stoch %K / %D58 / 59

ADX (14)16

+DI / −DI18 / 23

RSI divergence—

MACD divergence—

ATR %+5.51%

ADR %5.24%

52w high25.52

52w low4.31

From 52w high-46.24%

Above 52w low+218.33%

New 52w highNo

SqueezeOff

Bollinger width17.86%

%B0.45

Donchian pos43.12%

Donchian high15.29

Donchian low12.53

AVWAP (52w high)15.85

vs AVWAP high-13.45%

AVWAP (52w low)14.53

vs AVWAP low-5.56%

OBV trendFlat

Chaikin MF (20)0.05

Today vs 20d2.86×

Avg vol (14d)938.9K

Avg vol (20d)940.71K

Avg $ vol (20d)13.05M

Market cap1.15B

RS 3m (vs SPY)-10.29%

RS 6m (vs SPY)-41.08%

RS line new highNo

Trend template4/8

Technical rank32.0

1 week+2.62%

1 month-12.44%

3 months-11.77%

6 months-32.94%

1 year+232.20%

YTD+87.43%

P/E-75.52

P/B5.12

P/S—

P/FCF-35.00

EPS-0.5300

Div yield—

ROE-6.78%

ROA-6.39%

Debt/Eq—

Current16.16

EV/EBITDA-26.48

Gross margin—

Net margin—

Rev growth—

EPS growth75.47%

Price target31.60

Target upside130.32%

Analyst ratingBuy

Institutional90.70%

Ent. value1.14B

Revenue—

Net income-17.96M

Gross profit—

Free cash flow-32.97M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out84.09M

Employees37

ListedWed, Mar 23, 2016

Free float58.06M

Float %69.3%

Short interest18.06M

Days to cover12.6d

Short volume53.1%

Squeeze score89 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.19 vs −$0.17

Last surprise-11.8% miss

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank32.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance16.17

Support13.22

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRVS

All disclosures →

No recent disclosed trades by Congress in CRVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CRVS · 3 buys

Insider	Side	Shares	Value	Traded	Filed
MILLER RICHARD A MD President and CEO · Common Stock · 2026-05-18	Buy	5K	$60K	2026-05-18	2026-05-20
MILLER RICHARD A MD President and CEO · Common Stock · 2026-05-18	Buy	1.93K	$23K	2026-05-18	2026-05-20
MILLER RICHARD A MD President and CEO · Common Stock · 2026-05-18	Other	—	—	2026-05-18	2026-05-20
Chan Andrew C. Director · Stock Option (Right to Buy) · 2026-04-23	Grant	30K	$0	2026-04-23	2026-04-27

SEC filings

EDGAR filings in CRVS · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.